Assessment of the pharmacodynamic profile of DX-9065a, a direct factor Xa inhibitor, in 36 healthy male subjects: A first study using subcutaneous route - Depasse, F; Caplain, H; Kunitada, S (Thromb Haemost Suppl, 2001)
July